Highlights Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:56 2024-04-26 am EDT			5-day change	1st Jan Change
1,954 ^DKK	+2.04%		-2.57%	-9.30%

Apr. 16	Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	MT
Apr. 16	Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	Apr. 16	MT
Health Care Slips on Risk Bias -- Health Care Roundup	Apr. 11	DJ
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	Apr. 03	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	Apr. 03	DJ
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	Apr. 03
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	Apr. 03	DJ
Correction to Genmab Article	Apr. 03	DJ
Genmab: acquisition of ProfoundBio greeted without emotion	Apr. 03	CF
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	Apr. 03	DJ
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	Apr. 03	CI
News Highlights : Top Company News of the Day - Wednesday at 5 AM ET	Apr. 03	DJ
Genmab Strengthens Oncology Portfolio With $1.8 Billion Acquisition of ProfoundBio	Apr. 03	DJ
Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio	Apr. 03	MT
Denmark's Genmab to acquire ProfoundBio for $1.8 billion	Apr. 03	RE
Genmab to Acquire ProfoundBio for $1.8 Billion	Apr. 03	MT
Genmab to Purchase US-based ProfoundBio for $1.8 Billion	Apr. 03	MT
Genmab A/S entered into a definitive agreement to acquire ProfoundBio for $1.8 billion.	Apr. 02	CI
Genmab A/S commences an Equity Buyback Plan under the authorization approved on March 13, 2024.	Mar. 25	CI
Genmab Completes Share Buyback Program	Mar. 18	MT
Tranche Update on Genmab A/S's Equity Buyback Plan announced on February 14, 2024.	Mar. 18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 06:10 am EST